Prevention of psoriasis‐like lesions development in fsn/fsn mice by helminth glycans
Authors:
- 10 May 2006
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 15 (6) , 461-468
Abstract
Abstract: The helminth glycan LNFPIII is an immunomodulatory molecule, driving CD4+ Th2‐type biasing as well as immune suppression. Psoriasis is an autoimmune disease where the immune mechanisms as well as the antigens responsible for development of immune autoreactivity are still not known. In the absence of defined immunological mechanisms, we asked whether LNFPIII would function as novel therapy for psoriasis. We tested the therapeutic efficacy of LNFPIII using the flaky skin (fsn)/fsn mutant mouse model of psoriasis‐like lesion development. We found that treatment of mice with LNFPIII prevented the appearance of psoriatic skin lesions on fsn/fsn mice. Examination of the skin 2 weeks after treatment demonstrated that prevention of skin lesions was associated with maintenance of normal epidermis thickness in LNFPIII‐treated mice as compared with a significantly thickened epidermis in control treated and diseased mice. In addition, cells from skin of LNFPIII‐treated mice produced lower amounts of interferon‐γ as compared with cells from skin of control treated diseased mice. Examination of macrophages and T cells from peripheral lymph nodes of control and LNFPIII‐treated fsn/fsn mice showed that glycan treatment reduced the numbers of Gr1+F4/80+ macrophages and the numbers of CD8+ T cells, restoring the numbers of these two cell populations as well as the CD4 : CD8 ratio to near normal levels. Overall, the results from this study suggest that the helminth immunomodulatory glycan LNFPIII functions to prevent development of psoriatic‐like skin lesions in fsn/fsn mice.Keywords
This publication has 47 references indexed in Scilit:
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- PsoriasisNew England Journal of Medicine, 2005
- A worm's eye view of the immune system: consequences for evolution of human autoimmune diseaseNature Reviews Immunology, 2005
- Correlation of psoriasis activity with abundance of CD25+CD8+ T cells: conditions for cloning T cells from psoriatic plaquesExperimental Dermatology, 2004
- Schistosomiasis Decreases Central Nervous System Inflammation and Alters the Progression of Experimental Autoimmune EncephalomyelitisInfection and Immunity, 2003
- Lewisx-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasisHuman Immunology, 2000
- Inflammatory Skin Diseases, T Cells, and Immune SurveillanceNew England Journal of Medicine, 1999
- Animal Models of Psoriasis – What Can We Learn from Them?Journal of Investigative Dermatology, 1999
- Increased Epidermal Growth Factor Receptor in fsn/fsn MiceJournal of Investigative Dermatology, 1996
- Cytokine Regulation of Proliferation and ICAM-1 Expression of Human Dermal Microvascular Endothelial Cells In VitroJournal of Investigative Dermatology, 1992